Nuzenio

Takeda Pharma

Takeda Pharma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 19 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 20:31:05 GMTTakeda Pharmaceutical (TAK) holder Elaine Shannon plans sale of 20,363 ADSs - Stock Titan
Mon, 10 Aug 2026 16:47:18 GMTPhysician Views Preview: Orzeyful arrives — Will Takeda's drug redefine narcolepsy treatment? - FirstWord Pharma
Mon, 10 Aug 2026 15:27:17 GMTSpotlight On: Takeda breaks new ground with narcolepsy approval as Alkermes and Eli Lilly wait in slipstream - FirstWord Pharma
Mon, 10 Aug 2026 11:33:33 GMTSilence Therapeutics aims at Takeda with new data in rare blood cancer - STAT
Mon, 10 Aug 2026 11:31:00 GMTSilence brings the noise to Takeda with phase 2 blood cancer win - Fierce Biotech
Sat, 08 Aug 2026 11:46:03 GMTShould FDA Approval of ORZEYFUL for Narcolepsy Type 1 Prompt Action From Takeda Pharmaceutical (TSE:4502) Investors? - simplywall.st

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Takeda Pharma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

19 distinct publisher/source names are currently connected to this entity page.